Crisaborole
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 293 publications
The evolving landscape of phosphodiesterase inhibitors in atopic dermatitis management.
Journal: Expert opinion on pharmacotherapy
Published: August 14, 2026
Boron-Containing Drug Candidates in Clinical Trials.
Journal: Handbook of experimental pharmacology
Published: August 05, 2026
A multicenter study of crisaborole use in pediatric patients with atopic dermatitis in real-world setting in Thailand.
Journal: Asian Pacific journal of allergy and immunology
Published: July 29, 2026
Efficacy and safety of crisaborole ointment combined with 308-nm excimer laser in the treatment of non-segmental vitiligo: a randomized, intra-patient left-right controlled study protocol.
Journal: The Journal of dermatological treatment
Published: July 18, 2026
Topical Therapy for Atopic Dermatitis: What is New and the New Paradigm.
Journal: Immunology and allergy clinics of North America
Published: July 09, 2026
Synergistic antifungal effects and potential mechanisms of crisaborole combined with azoles against drug-resistant Candida albicans.
Journal: Expert review of anti-infective therapy
Published: June 23, 2026
Boron-Based Bioisosteres in Medicinal Chemistry: Advances in Heterocycles and Therapeutic.
Journal: ChemMedChem
Published: June 03, 2026
Ten specific updates for the Mexican atopic dermatitis guidelines, GUIDAMEX 1.1.
Journal: Boletin medico del Hospital Infantil de Mexico
Published: May 21, 2026
Skin Allergy Research Society and Society for Eczema Studies Joint Task Force Guidelines of Care for Management of Atopic Dermatitis for Adults, Children, and Special Populations in India: An Evidence-Based Review and an Expert Consensus.
Journal: Indian journal of dermatology
Published: May 11, 2026
Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials.
Journal: Dermatology and therapy
Published: May 07, 2026
Pde4 mediates MHCII expression in oligodendroglia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 05, 2026
Case Report: Treatment of trachyonychia in children with crisaborole: a retrospective case series.
Journal: Frontiers in pediatrics
Published: April 25, 2026
Last Updated: 09/26/2026